Name | WAP four-disulfide core domain 1 |
Symbol | WFDC1 |
Aliases | PS20; prostate stromal protein ps20; WAP four-disulfide core domain 1 homolog (mouse) |
Gene Product | - WAP four-disulfide core domain 1 precursor
|
Category | - Gross deletion in Prostate cancer
|
UniGene | Hs.36688 |
OMIM | 605322 |
Locus | 58189 |
Summary | This gene encodes a member of the WAP-type four disulfide core domain family. The WAP-type four-disulfide core domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor in many family members. The encoded protein shares 81% amino acid identity with the rat ps20 protein, which was originally identified as a secreted growth inhibitor. This gene is mapped to chromosome 16q24, an area of frequent loss of heterozygosity in cancers, including prostate, breast and hepatocellular cancers and Wilms' tumor. Owing to its location and a possible growth inhibitory property of its gene product, this gene is suggested to be a tumor suppressor gene. |
Expression | EST (68 ESTs, 33 libraries) |
Tissue ? |
Frequency ? |
Count ? |
brain (4/204) | | 11/362011 |
colon (2/853) | | 2/165626 |
eye (2/33) | | 3/93836 |
germ cell (1/7) | | 1/57383 |
heart (1/22) | | 1/55494 |
kidney (1/86) | | 1/132968 |
liver (1/38) | | 1/46472 |
placenta (2/342) | | 8/157762 |
prostate (4/291) | | 9/109871 |
stomach (2/312) | | 2/129930 |
testis (1/171) | | 2/117531 |
uncharacterized tissue (11/1773) | | 24/713325 |
uterus (1/212) | | 3/155110 |
|
SAGE (547151 tags, 9 libraries) |
Tissue ? |
Frequency ? |
Count ? |
brain (3/19) | | 3/218747 |
cerebellum (1/1) | | 1/51280 |
eye (1/6) | | 1/59661 |
kidney (1/2) | | 1/41857 |
ovary (1/10) | | 1/39049 |
prostate (1/13) | | 2/59553 |
uncharacterized tissue (1/22) | | 1/77004 |
|
|
SNP | rs432434 (G/C:intron);  rs184955 (T/G:intron);  rs606582 (T/C:intron);  rs181740 (G/C:intron);  rs400515 (C/T:intron);  rs619994 (G/C:intron);  rs453630 (A/G:intron);  rs9910 (A/T:mrna-utr);  rs367045 (T/A:intron);  rs381107 (T/C:intron);  rs454605 (G/C:intron);  rs431596 (T/C:intron);  rs423666 (C/T:intron);  rs375932 (A/G:intron);  rs824292 (C/T:intron);  rs187372 (G/A:intron);  rs388905 (A/G:intron);  rs2113302 (A/T:intron);  rs1306488 (T/G:intron);  rs445141 (C/T:intron);  rs432666 (A/G:locus-region);  rs429725 (G/A:intron);  rs1862806 (A/G:intron);  rs193460 (C/T:intron);  rs424043 (C/A:intron);  rs448161 (C/T:intron);  rs364836 (C/G:intron);  rs2326205 (A/G:intron);  rs401782 (C/G:intron);  rs399209 (T/C:intron);  rs401760 (G/T:intron);  rs448305 (T/G:locus-region);  rs408216 (G/A:intron);  rs400345 (G/A:mrna-utr);  rs2288027 (T/A:intron);  rs401321 (T/C:intron);  rs244782 (A/G:intron);  rs420744 (C/A:locus-region);  rs375287 (C/T:intron);  rs889712 (G/T:locus-region);  rs396395 (C/T:intron);  rs369797 (T/G:intron);  rs173429 (C/T:intron);  rs393430 (C/T:intron);  rs2550486 (C/A:mrna-utr);  rs430002 (T/A:intron);  rs389336 (G/T:intron);  rs613604 (C/G:locus-region);  rs375427 (A/G:locus-region);  rs193462 (A/G:intron);  rs4557 (C/T:mrna-utr);  rs2161700 (G/A:intron);  rs444744 (G/A:locus-region);  rs370578 (G/T:intron);  rs2042434 (G/T:intron);  rs437216 (C/G:intron);  rs428610 (T/G:intron);  rs244827 (A/G:intron);   |
Evidence | Gross deletion in Prostate cancer
|